Compare Devon Energy Corp (DVN) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs TG Therapeutics Inc — how do they compare? Devon Energy Corp trades at $48.26 (market cap $53.81B), while TG Therapeutics Inc trades at $55.37 (market cap $8.16B). The key difference: Devon Energy Corp is far larger — about 6.6× TG Therapeutics Inc's market cap, and Devon Energy Corp pays a 2.62% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and TG Therapeutics Inc for 16 Days on average.
| DVN | TGTX | |
|---|---|---|
Market Cap | $53.81B | $8.16B |
Volume | 11,556,740 | 1,735,121 |
Sector | Energy | Health |
52-Week High | $52.07 | $59.06 |
52-Week Low | $31.74 | $26.94 |
Typical Hold Time | 136 Days | 16 Days |
Enterprise Value | $64.55B | $8.37B |
Dividend Yield | 2.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $48.92, up 2.17% today, with strong analyst support showing 72% buy ratings and a $62.53 consensus price target. The stock shows bullish technical momentum above key support levels, while fundamentals reveal solid profitability with 16.67% net margins and attractive valuation at 10.63 P/E. Recent activist pressure from Toms Capital for strategic alternatives and potential asset sales with BP creates near-term catalysts.
DVN presents compelling value with upside potential to analyst targets, though faces execution risks on asset sales and oil price volatility. The company's improving cash flow generation and Permian Basin focus support the bullish case, but investors should monitor activist developments and energy market conditions closely.
TG Therapeutics (TGTX) trades at $53.34, up 0.74% today, but faces bearish technical signals despite strong profitability metrics like a 55.22% net income margin. Recent earnings misses and a shareholder investigation create headwinds, though revenue growth and a high analyst buy consensus of 84.62% suggest underlying strength. The stock's current price is near key support at $52, with resistance at $54.
The outlook is mixed: robust revenue growth and institutional buying support upside toward the $80.50 consensus target, but earnings misses and legal risks pose challenges. Investors should weigh the company's MS therapy momentum against execution and regulatory uncertainties for balanced risk-reward assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
